Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.


NDAQ:NVCN - Post by User

Neovasc Inc. > BS analyst forcasts
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(6)
•••
Comment by Sanderzon Apr 24, 2018 9:20am
66 Views
Post# 27931053

RE:BS analyst forcasts

RE:BS analyst forcasts
pdesj2000 wrote: I think what bothers me the most about this whole dilution process is that after everything 
that happened, most analysts still maintain that this is a strong buy. After looking at their firecasts
over the last 2-3 years, no wonder people are losing money. They have been totally off since the beginning. 



I agree, Analysts' target prices don't mean anything!   Just because they give a target price does not mean it WILL be that price.  I can give this ANY target price I want, even if it's within reason, does that mean it will happen? Nope.     I've said this many times before, I've yet to see any "target price" actually happen.    I'm sure it happens once in a while, but more often than not the target price is never reached.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities